CN107467670A - A kind of probiotics preparation and preparation method and application - Google Patents
A kind of probiotics preparation and preparation method and application Download PDFInfo
- Publication number
- CN107467670A CN107467670A CN201710854857.3A CN201710854857A CN107467670A CN 107467670 A CN107467670 A CN 107467670A CN 201710854857 A CN201710854857 A CN 201710854857A CN 107467670 A CN107467670 A CN 107467670A
- Authority
- CN
- China
- Prior art keywords
- probiotics preparation
- probiotics
- purslane
- preparation
- pepsin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 93
- 239000006041 probiotic Substances 0.000 title claims abstract description 81
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 81
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 36
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 36
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 33
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 33
- 229940111202 pepsin Drugs 0.000 claims abstract description 33
- 241000194032 Enterococcus faecalis Species 0.000 claims abstract description 28
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 28
- 241000219304 Portulacaceae Species 0.000 claims abstract description 28
- 229940032049 enterococcus faecalis Drugs 0.000 claims abstract description 28
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 21
- 230000036541 health Effects 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 13
- 244000005700 microbiome Species 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 3
- 206010010774 Constipation Diseases 0.000 abstract description 16
- 230000000968 intestinal effect Effects 0.000 abstract description 12
- 238000000855 fermentation Methods 0.000 abstract description 9
- 230000004151 fermentation Effects 0.000 abstract description 9
- 230000000474 nursing effect Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 241000726221 Gemma Species 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 11
- 244000052616 bacterial pathogen Species 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 230000001225 therapeutic effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000009965 odorless effect Effects 0.000 description 6
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 239000004459 forage Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940036811 bone meal Drugs 0.000 description 2
- 239000002374 bone meal Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 231100000284 endotoxic Toxicity 0.000 description 2
- 230000002346 endotoxic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- -1 lactic acid Chemical class 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 238000005461 lubrication Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 108010026389 Gramicidin Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RKLXDNHNLPUQRB-TVJUEJKUSA-N chembl564271 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]2C(C)SC[C@H](N[C@@H](CC(N)=O)C(=O)NC(=O)[C@@H](NC2=O)CSC1C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NC(=C)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H]1NC(=O)C(=C\C)/NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H]3CCCN3C(=O)[C@@H](NC(=O)[C@H]3N[C@@H](CC(C)C)C(=O)NC(=O)C(=C)NC(=O)CC[C@H](NC(=O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC=4C5=CC=CC=C5NC=4)CSC3)C(O)=O)C(C)SC2)C(C)C)C(C)SC1)C1=CC=CC=C1 RKLXDNHNLPUQRB-TVJUEJKUSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000002618 gastric chief cell Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003450 growing effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940041153 polymyxins Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 108010082567 subtilin Proteins 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/23—Aspartic endopeptidases (3.4.23)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/225—Faecalis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Physiology (AREA)
- Sustainable Development (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a kind of probiotics preparation and preparation method and application, the probiotics preparation includes by mass percentage:30 45% bacillus subtilis, 5 20% bacillus licheniformis, 20 40% enterococcus faecalis, 20 35% pepsin, 0 5% purslane.The probiotics preparation can be applied in the health products, food, medicine or the feed that are used for nursing one's health enteric microorganism environment is prepared, it can effectively treat the constipation caused by intestinal flora is lacked of proper care, the probiotics preparation can also be applied in fermented feed is prepared simultaneously, and it can greatly shorten the fermentation time of fermented feed.
Description
Technical field
The invention belongs to biological technical field, and in particular to a kind of probiotics preparation and preparation method and application.
Background technology
Live away from home miscellaneous microorganism in the enteron aisle of healthy humans and animals, and these microorganisms are referred to as gut flora.Intestines
Road flora combines according to a certain percentage, conditions each other, depends on each other for existence between each bacterium, forms a kind of ecological balance on quality and quantity, and one
Denier body internal and external environment changes, such as diet changes, using antibiotic medicine, intestinal immunity obstacle etc., leads
Sensitization intestines bacterium is pressed, and not repressed bacterium seizes the opportunity breeding, so as to cause flora imbalance, human or animal is produced corresponding disease
Disease.
Normal fecal stools contain 70-80% moisture content, and the holding of these moisture content just has benefited from the attachment and presence of intestinal flora.
So maintaining the health of body, it is very necessary to keep enteral beneficial bacterium dominance.If there is no gut flora in enteron aisle,
Such as eaten antibiotic and gut flora is largely all killed, also just without the perfect adaptation of flora and moisture content in excrement,
Excrement is done not only firmly, cause constipation.
The medicine for the treatment constipation clinically commonly used at present has:Bulk cathartic, irritant laxative, emollient cathartic, ooze
Permeability caccagogue, intestinal motive force medicine, probiotics etc., though effective, its side effect in treatment constipation of these medicines
It is fairly obvious, there is injury to humans and animals.There are the probiotics preparation of a little treatment constipation, these probiotic products bacterium above market
Number is high, but is protected due to lacking, and it is really seldom to successfully arrive at the number of viable of enteron aisle fixed point breeding, causes treatment cycle generally inclined
It is long, it is impossible to the timely and effectively pain of relief of constipation patient.
The content of the invention
The present invention first purpose be to provide a kind of probiotics preparation, the probiotics preparation using probiotics suppress have
Evil bacterium, can nurse one's health enteric microorganism environment, make beneficial bacterium dominance in enteron aisle, treat caused by intestinal flora is lacked of proper care just
It is secret;Meanwhile make the excrement desaturation in enteron aisle by pepsin, excrement is smoothly discharged, and the excrement odorless discharged, the benefit
Probiotics preparation is rapid-action, significant effect, moreover it is possible to improves the digestive function and immunologic function of human body and animal.
To achieve the above object, probiotics preparation provided by the invention, it includes by mass percentage:30-45%'s
Bacillus subtilis, 5-20% bacillus licheniformis, 20-40% enterococcus faecalis, 20-35% pepsin, 0-5%
Purslane.
As a preference of the present invention, probiotics preparation provided by the invention, it includes by mass percentage:30-40%
Bacillus subtilis, 10-20% bacillus licheniformis, 25-35% enterococcus faecalis, 20-30% pepsin, 2-
5% purslane.
As present invention further optimization, probiotics preparation provided by the invention, it includes by mass percentage:
35% bacillus subtilis, 10% bacillus licheniformis, 30% enterococcus faecalis, 22% pepsin, 3% dent
Amaranth.
As the present invention still more preferably, probiotics preparation provided by the invention when specifically used can by its with
Glucide carries out compatible use, and the glucide addition is at least 3 times of probiotics preparation;The glucide is preferred
The higher material of the sugar content such as brown sugar, white sugar or glucose or honey, it can also be other monose or oligosaccharides.Sugar
Class material has proliferation function to bacillus subtilis, bacillus licheniformis, enterococcus faecalis, makes bacillus subtilis, lichens gemma
Bacillus, enterococcus faecalis take advantage in enteron aisle, improve therapeutic effect.
Probiotics preparation provided by the invention, in every gram of microorganism group mixture, viable count is 10,000,000,000-110 hundred million, ensures benefit
Probiotics preparation can produce effective adjustment effect to animal intestinal tract.
Second object of the present invention is to provide a kind of preparation method of probiotics preparation:Specifically include following steps:
(1) purslane after drying is weighed by above-mentioned mass percent, is crushed with pulverizer, sieved, obtain purslane
Fine powder;
(2) purslane fine powder is mixed with bacillus subtilis, bacillus licheniformis, enterococcus faecalis, pepsin
Uniformly.
Third object of the present invention is that providing a kind of probiotics preparation is preparing for nursing one's health enteric microorganism environment
Health products, food, the application in medicine or feed, the probiotics preparation can improve the composition of flora in host intestine, in advance
Anti- and improvement constipation, its is rapid-action, has no side effect, and the excrement odorless discharged.
Fourth object of the present invention is in providing a kind of application of probiotics preparation in fermented feed is prepared, by 3-5
The probiotics preparation of parts by weight, the water of 300-500 parts by weight treat that fermented feed is mixed with 1000-1200 parts by weight, under normal temperature
Fermentation, the probiotics preparation can make feed be fermented in 16-32 hours completion, greatly shorten the feed fermentation time;Meanwhile
After the forage feed animal after probiotics fermention, the nutritional ingredient in feed can all be absorbed, and animal defecation is normal, can
Grow up healthy and sound, and immunity improves, and the illnesss such as aftosa will not occur.
Probiotics preparation provided by the invention in preparing fermented feed when applying, preferably by probiotics preparation and sugared compatibility
Use, i.e., by the probiotics preparation of 3-5 parts by weight, the sugar of 50-100 parts by weight, 300-500 parts by weight water and 1000-1200
Parts by weight treat that fermented feed is mixed, and are fermented under normal temperature, and fermentation time can further be shortened by adding sugar, make fermentation time
Completed in 12 hours, the fermentation time occupies first place in the world.Described sugar is brown sugar, white sugar, glucose eaten etc., can also
It is other monose or oligosaccharides.
The function of each raw material is as follows in probiotics preparation provided by the invention:
Bacillus subtilis, special thalline is carried out promoting gemma and microcapsules coating is handled, in spore state stability inferior
It is good, energy resistance to oxidation, anti-extrusion, high temperature resistant, acid and alkali-resistance, activity is kept in acid stomach, the attack of saliva and bile is resistant to, is micro-
In biology can 100% through intestine and small intestine viable bacteria.Adding bacillus subtilis mainly has some following effect;One:Withered grass gemma
Caused subtilin, polymyxins, nystatin, gramicidins isoreactivity material during bacillus thalli growth, these work
Property material has obvious inhibitory action to the conditioned pathogen of pathogenic bacteria or autogenous infection;Meanwhile bacillus subtilis is rapid
The free oxygen in environment is consumed, causes enteron aisle hypoxemia, is promoted beneficial to anaerobism bacteria growing, and produces the organic acids such as lactic acid, is reduced
Enteron aisle pH value, suppress other pathogenic bacteria growings indirectly.Two:Bacillus subtilis can improve immunoglobulin and antibody level,
Strengthen cellular immunity and humoral immune function, improve herd immunity;Meanwhile bacillus subtilis thalline itself synthesis alphalise starch
The enzymes such as enzyme, protease, lipase, cellulase, together played with the digestive enzymes in animal body (human body) in alimentary canal
Effect, improve the digestive function of body.Three:Bacillus subtilis by with competition of the pathogen to nutrient, suppress pathogen,
Intestinal microecology balance is adjusted, forms biological containment.Meanwhile its metabolite lactic acid and bacteriocin are harmful with other are suppressed
Bacterium maintains and ensured the stabilization of the combination of flora optimal vigor and this combination, prevent pathogenic in the effect of enteron aisle internal breeding
Bacterium colonizing and invading, and suppresses pathogenic bacteria and harmful microbe growth and its toxin sticks;Four:Bacillus subtilis is to leather
Blue positive and Grain-negative pathogenic bacteria have inhibitory action, and bacillus subtilis can suppress Escherichia coli and detection of Salmonella pair
Caco-2 cells stick, so as to prevent its colonizing in enteron aisle;Five:There is bacillus subtilis good enteron aisle to stick spy
Property.Bacillus subtilis and competition of the pathogenic bacteria to mannose specific receptor, reduce pathogenic bacteria and human body cell are sticked,
So as to protect host from infection.
Bacillus licheniformis, cellular morphology and arrangement are in shaft-like, Dan Sheng, and adjustable flora imbalance reaches therapeutic purposes, can
Body is promoted to produce antibacterial substance, kill pathogenic bacteria.Resistant activity material can be produced, and takes oxygen effect by force with unique biology
Mechanism, the growth and breeding of pathogenic bacteria can be suppressed.In addition, bacillus licheniformis has stronger protease, lipase, amylase
Activity, body can be promoted to absorb nutriment, strengthen immunity of organisms;Meanwhile promote normal physiological in enteron aisle
Property anaerobic bacteria growth, adjust intestinal bacilli illness, recover function of intestinal canal.
Enterococcus faecalis, there is stronger tolerance and colonization ability in intestinal mucosa, natural antibiotics can be produced, be advantageous to body
Health;The antibacterial substances such as bacteriocin can also be produced simultaneously, suppress the growth of the pathogen such as Escherichia coli and salmonella, improve intestines
Road microenvironment, moreover it is possible to suppress the breeding of urease-producing bacterium and spoilage organisms in enteron aisle, reduce enteron aisle urease and endotoxic contain
Amount, decline ammonia and endotoxic content in blood.Enterococcus faecalis is used cooperatively with bacillus subtilis and bacillus licheniformis,
Bacillus subtilis and bacillus licheniformis have the function that promotion enterococcus faecalis propagation, further enhance therapeutic effect.
Pepsin, it is a kind of digestibility pepsin, by the gastric chief cells (gastric in stomach
Chiefcell it is) secreted, can be small fragments of peptides by the breaks down proteins in food, pepsin is a kind of acid stomach cardia
Enzyme, the peptide bond that can be formed by aromatic amino acid or acidic amino acid in decomposing protein, therefore casein, ball egg can be catalyzed
In vain, histone, the keratin in horn, nail and feather, and the hydrolysis of catalysis vegetable protein etc..Added in the present invention
Pepsin mainly has following two purposes;One:Nutrient is provided for bacillus subtilis, bacillus licheniformis, enterococcus faecalis, is made
More through enteron aisles of viable bacterias, promote the growth of beneficial bacterium in enteron aisle.Two:Food is promoted to make in enteron aisle in stomach decomposition and inversion
Excrement desaturation, aid in intestinal movement, reduce the chance that is contacted with noxious material of enteron aisle, suppress absorption and the promotion of harmful substance
Excretion.
Purslane, it is cold in nature, enter the heart, liver, spleen, large intestine channel, there is clearing heat and detoxicating, sharp water clearing damp, blood-stanching and blood-cooling, anti-inflammatory analgetic
And other effects, the immunity of body can also be strengthened, so as to improve the regulating power of body, Virus entry human body is avoided, in withered grass
Purslane is added in bacillus, bacillus licheniformis, enterococcus faecalis, pepsin, because purslane can make enteron aisle more
Lubrication, make excrement excretion more unobstructed, can greatly shorten the time for the treatment of constipation, the pain of timely relief of constipation person, its
Make the excrement odorless of discharge with pepsin synergy.
The advantages of the present invention:
(1) probiotics preparation provided by the invention is by adding bacillus subtilis, bacillus licheniformis, enterococcus faecalis,
And its ratio is adjusted, it can nurse one's health enteric microorganism environment, improve the composition of flora in host intestine, utilize benefit
Raw bacterium suppresses harmful bacteria, can quickly adjust the constipation caused by intestinal flora is lacked of proper care.
(2) probiotics preparation provided by the invention is on the one hand bacillus subtilis, lichens bud by adding pepsin
Spore bacillus, excrement intestines intestines bacterium provide nutrition, more viable bacterias go directly enteron aisle, on the other hand by pepsin acceleration food in stomach
The decomposition and inversion in portion, the digestive function of body is improved, make the excrement desaturation in enteron aisle, aid in intestinal movement, further improved just
It is secret.
(3) probiotics preparation provided by the invention is by adding purslane toxin expelling, fall fire, while increases the lubrication of enteron aisle
Property, it is used cooperatively with bacillus licheniformis, enterococcus faecalis, pepsin, makes excrement excretion more unobstructed, shortens treatment constipation
Time, synergy makes the excrement odorless of discharge with pepsin for it.
(4) probiotics provided by the invention passes through bacillus subtilis, bacillus licheniformis, enterococcus faecalis, pepsin
With the effect of purslane, it adjusts the positive effect of intestinal flora imbalance, a variety of probiotics can be made to be colonized in enteron aisle, adjusts
People balances with microbial population of animal intestinal tract, so as to improve the immunity of body and microbial environment degree, can effectively treat because of intestines
Constipation caused by flora imbalance, rapid-action in road, and the cycle for treating constipation is shorter, moreover it is possible to the immunity of body itself is improved, from
Fundamentally solves constipation.
(5) when probiotics provided by the invention is used cooperatively with sugar, it is possible to increase the activation efficiency of probiotics, be used in
The fermentation time of feed can be greatly shortened in fermented feed, feed original fermentation time was shortened to 12-32 hours by 28 days;Together
When, after using the forage feed animal of the probiotics fermention, the nutritional ingredient in feed can all be absorbed, the body of animal
In order, the speed of growth is fast, and immunity improves, and does not have an injection and does not take medicine, must not aftosa.
Embodiment
To make those skilled in the art be better understood from the purpose, technical scheme and advantage that the present invention is implemented, with reference to
Specific implementation case describes while clear, completion is carried out to technical scheme, but is not used to the scope of the present invention
Restriction.
Embodiment 1
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 35%, lichens gemma
Bacillus 10%, enterococcus faecalis 35%, pepsin 20%, wherein, in every gram of probiotics preparation, viable count is 10,800,000,000.
Specific preparation method:The purslane after drying is weighed by above-mentioned mass percent, is crushed with pulverizer, mistake
Sieve, obtains purslane fine powder;Purslane fine powder and bacillus subtilis, bacillus licheniformis, enterococcus faecalis, pepsin are entered again
Row is well mixed.
Embodiment 2
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 30%, lichens gemma
Bacillus 20%, enterococcus faecalis 25%, pepsin 20%, purslane 5%, wherein, in every gram of probiotics preparation, viable count is
10500000000.
Specific preparation method:With embodiment 1.
Embodiment 3
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 40%, lichens gemma
Bacillus 5%, enterococcus faecalis 23%, pepsin 30%, purslane 2%, wherein, in every gram of probiotics preparation, viable count 101
Hundred million.
Specific preparation method:With embodiment 1.
Embodiment 4
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 45%, lichens gemma
Bacillus 10%, enterococcus faecalis 20%, pepsin 20%, purslane 5%, wherein, in every gram of probiotics preparation, viable count is
10500000000.
Specific preparation method:With embodiment 1.
Embodiment 5
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 30%, lichens gemma
Bacillus 10%, enterococcus faecalis 20%, pepsin 35%, purslane 5%, wherein, in every gram of probiotics preparation, viable count is
10000000000.
Specific preparation method:With embodiment 1.
Embodiment 6
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 30%, lichens gemma
Bacillus 5%, enterococcus faecalis 40%, pepsin 22%, purslane 3%, wherein, in every gram of probiotics preparation, viable count 107
Hundred million.
Specific preparation method:With embodiment 1.
Embodiment 7
The probiotics preparation that the present embodiment provides, includes by mass percentage:Bacillus subtilis 35%, lichens gemma
Bacillus 10%, enterococcus faecalis 30%, pepsin 22%, purslane 3%, wherein, in every gram of probiotics preparation, viable count is
10700000000.
Specific preparation method:With embodiment 1.
Comparative example 1
A kind of probiotics preparation, includes by mass percentage:Bacillus subtilis 45%, bacillus licheniformis 20%,
The pepsin of enterococcus faecalis 20%, 15%, wherein, in every gram of probiotics preparation, viable count is 11,000,000,000.
Comparative example 2
A kind of probiotics preparation, includes by mass percentage:Bacillus subtilis 45%, lichens gemma bar 10%, excrement
Enterococcus 30%, pepsin 12%, purslane 3%, wherein, in every gram of probiotics preparation, viable count is 11,000,000,000.
The applicable cases of probiotics preparation of the present invention clinically are as follows:
1st, case selection:
This group of case be because intestinal flora lack of proper care caused by constipation patient, meet include, exclusion standard, the age
Between 20-65 year, wherein, man accounts for 50%, Ms and accounts for 50%.It is randomly divided into 12 groups, every group each 20, wherein experimental group is the
1~9 group, control group is 10-12 groups.There was no significant difference for the data such as age of this 12 groups of patients, sex, the state of an illness, and having can
Compare property.
2nd, therapeutic scheme:
1st~7 group of (experimental group) patient takes the preparation that embodiment 1~7 is provided respectively, once a day, each 1.5g;
8th group (experimental group), the preparation that the 9th group (experimental group) takes embodiment 6 respectively, embodiment 7 is provided, and after preparation is taken
Take 5g white sugar in addition, the preparation that the 10th group of (control group) edible for patients comparative example 1 is provided, once a day, and each 1.5g,
The preparation that 11 groups of (control group) edible for patients comparative examples 1 are provided, once a day, each 1.5g, and after preparation is taken in addition
Take 5g white sugar;The preparation that 12nd group of (control group) edible for patients comparative example 2 is provided, once a day, each 1.5g.
Observe and record:After medication 7 days, record the state of an illness after 15 days, after 30 days respectively, and according to " significant effect ",
" effective ", engineering noise these three grades are evaluated come the therapeutic action to the medicament.
3rd, clinical evaluation standard:
Significant effect:Patient defecates 1-2 times/day, and just matter is soft, odorless, does not glue urinal.
Effectively:Patient defecates 2 once, and just matter need to continue to take medicine close to normally.
It is invalid:Patient defecates situation without significant change.
4th, observed after taking 7 days, as a result as shown in table 1:
The clinical test results of table 1
Project | Significant effect (example) | Effectively (example) | Invalid (example) |
Experimental group 1 | 13 | 7 | 0 |
Experimental group 2 | 17 | 3 | 0 |
Experimental group 3 | 17 | 3 | 0 |
Experimental group 4 | 18 | 2 | 0 |
Experimental group 5 | 16 | 4 | 0 |
Experimental group 6 | 17 | 3 | 0 |
Experimental group 7 | 18 | 2 | 0 |
Experimental group 8 | 19 | 1 | 0 |
Experimental group 9 | 19 | 1 | 0 |
Control group 1 | 0 | 6 | 14 |
Control group 2 | 0 | 8 | 12 |
Control group 3 | 2 | 9 | 9 |
5th, observed after taking 15 days, as a result as shown in table 2:
The clinical test results of table 2
Project | Significant effect (example) | Effectively (example) | Invalid (example) |
Experimental group 1 | 16 | 4 | 0 |
Experimental group 2 | 19 | 1 | 0 |
Experimental group 3 | 18 | 2 | 0 |
Experimental group 4 | 19 | 1 | 0 |
Experimental group 5 | 18 | 2 | 0 |
Experimental group 6 | 19 | 1 | 0 |
Experimental group 7 | 20 | 0 | 0 |
Experimental group 8 | 20 | 0 | 0 |
Experimental group 9 | 20 | 0 | 0 |
Control group 1 | 1 | 9 | 10 |
Control group 2 | 1 | 11 | 8 |
Control group 3 | 5 | 10 | 5 |
6th, observed after taking 30 days, as a result as shown in table 3:
The clinical test results of table 3
It can be seen from the results above that the addition of pepsin is directly affected and controlled in probiotics preparation provided by the invention
Therapeutic effect, when pepsin addition is too low, its therapeutic effect is poor, even if long-term use of, effect is still undesirable.Meanwhile
Purslane is added in said preparation can increase therapeutic effect, hence it is evident that shorten treatment cycle;And the probiotics preparation and white sugar are same
When taking, it can further strengthen therapeutic effect.
As can be seen here, probiotics preparation provided by the invention can prepare the health care for nursing one's health enteric microorganism environment
Application in product, food, medicine or feed, improving the composition of flora in host intestine, prevention and improvement constipation, its is rapid-action,
Have no side effect, and the excrement odorless discharged.
Embodiment 8
Application of the probiotics preparation produced by the present invention in fermented feed is prepared.
1000 parts by weight agriculture grain crop (potato 20-25%, corn 18-20%, dregs of beans 5-10%, bone meal 2-5%,
Bean dregs 34-40%, vegetables 4-6%, melon seedling 7-10%) in add 3 parts by weight of example 7 made from probiotics preparation, 300 weights
The water of part is measured, is fermented under normal temperature state, can be prepared by fermented feed within 20 hours.
Embodiment 9
1000 parts by weight agriculture grain crop (potato 20-25%, corn 18-20%, dregs of beans 5-10%, bone meal 2-5%,
Bean dregs 34-40%, vegetables 4-6%, melon seedling 7-10%) in add 3 parts by weight embodiment 7 made from probiotics preparation, 300
The white sugar of the water of parts by weight, 50 parts by weight, ferment under normal temperature state, can be prepared by fermented feed within 12 hours.
By fermented feed feed for nursing pig made from embodiment 8, embodiment 9, feed pig does not have sick and raw in three months
Long the nutritional ingredient utilization rate in feed is high in order, eats the fermented feed and is growed compared with the pig of common fermentation forage feed
Faster, and the immunity of feed pig improves, and aftosa during which must not be crossed, also must cross other illnesss.
Claims (10)
- A kind of 1. probiotics preparation, it is characterised in that:Include by mass percentage:30-45% bacillus subtilis, 5-20% Bacillus licheniformis, 20-40% enterococcus faecalis, 20-35% pepsin, 0-5% purslane.
- A kind of 2. probiotics preparation according to claim 1, it is characterised in that:Include by mass percentage:30-40% Bacillus subtilis, 10-20% bacillus licheniformis, 25-35% enterococcus faecalis, 20-30% pepsin, 2-5% Purslane.
- A kind of 3. probiotics preparation according to claim 1, it is characterised in that:Include by mass percentage:35% it is withered Careless bacillus, 10% bacillus licheniformis, 30% enterococcus faecalis, 22% pepsin, 3% purslane.
- A kind of 4. probiotics preparation according to claim 1, it is characterised in that:Viable count is in every gram of probiotics preparation 10000000000-110 hundred million.
- 5. the preparation method of the probiotics preparation described in claim 1, it is characterised in that:Specifically include following steps:(1)The purslane after drying is weighed on request, is crushed with pulverizer, is sieved, is obtained purslane fine powder;(2)Purslane fine powder is well mixed with bacillus subtilis, bacillus licheniformis, enterococcus faecalis, pepsin .
- 6. the probiotics preparation described in claim 1 or 2 or 3 is preparing the health products for being used to nurse one's health enteric microorganism environment, eaten Application in product, medicine or feed.
- 7. a kind of probiotics preparation according to claim 6 prepare be used for nurse one's health enteric microorganism environment health products, Application in food, medicine or feed, it is characterised in that:It is described by probiotics preparation and glucide compatibility when specifically used Glucide addition is at least 3 times of probiotics preparation.
- 8. application of the probiotics preparation described in claim 1 or 2 or 3 in fermented feed is prepared.
- 9. application of the probiotics preparation according to claim 8 in fermented feed is prepared, it is characterised in that:It is specifically used When water and the 1000-1200 parts by weight of the probiotics preparation of 3-5 parts by weight, 300-500 parts by weight are treated that fermented feed mixes , fermented under normal temperature.
- 10. application of the probiotics preparation according to claim 9 in fermented feed is prepared, it is characterised in that:Specifically make Used time by probiotics preparation and glucide compatible use, by the probiotics preparation of 3-5 parts by weight, the sugar of 50-100 parts by weight Class material, water and the 1000-1200 parts by weight of 300-500 parts by weight treat that fermented feed is mixed, and ferment under normal temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710854857.3A CN107467670B (en) | 2017-09-20 | 2017-09-20 | Probiotic preparation and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710854857.3A CN107467670B (en) | 2017-09-20 | 2017-09-20 | Probiotic preparation and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107467670A true CN107467670A (en) | 2017-12-15 |
CN107467670B CN107467670B (en) | 2020-12-01 |
Family
ID=60585559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710854857.3A Active CN107467670B (en) | 2017-09-20 | 2017-09-20 | Probiotic preparation and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107467670B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108902517A (en) * | 2018-05-16 | 2018-11-30 | 浙江省中医药研究院 | A kind of probiotic composition and its application |
CN113430150A (en) * | 2021-08-11 | 2021-09-24 | 真爱生命生物技术(重庆)有限公司 | Probiotics and application thereof |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104039A (en) * | 1993-12-22 | 1995-06-28 | 黄明和 | Chengji additive for fodder |
CN101580799A (en) * | 2008-05-14 | 2009-11-18 | 北京大北农科技集团股份有限公司 | Micro-ecological preparation and application thereof |
CN102409015A (en) * | 2011-12-06 | 2012-04-11 | 北京大北农科技集团股份有限公司 | Composite microecological preparation, application thereof in feed additive and premix |
CN102559545A (en) * | 2011-12-15 | 2012-07-11 | 北京大北农科技集团股份有限公司 | Composite micro-ecological preparation for aquatic product and premix thereof |
CN102640855A (en) * | 2012-04-27 | 2012-08-22 | 杨洪星 | Micro ecological feed additive |
CN102106491B (en) * | 2011-02-24 | 2013-03-20 | 海一(厦门)生物科技有限公司 | High-activity biological fermentation feed for prawn and preparation method thereof |
CN103209600A (en) * | 2010-11-15 | 2013-07-17 | 雀巢产品技术援助有限公司 | Array of age-tailored nutritional formula with probiotics |
CN103349186A (en) * | 2013-08-01 | 2013-10-16 | 正大康地(澄海)有限公司 | Weaned piglet feed additive and preparation method thereof |
CN103583850A (en) * | 2012-08-17 | 2014-02-19 | 广州市纽溢乐商贸有限公司 | Preparation method of composite microecologics, and fermenting equipment of preparation method |
CN104206734A (en) * | 2014-09-03 | 2014-12-17 | 湛秀河 | Chinese medicinal herb nonreactor biological feed additive |
CN106306363A (en) * | 2016-07-20 | 2017-01-11 | 洛阳欧科拜克生物技术股份有限公司 | Composite probiotic product formula and production technology thereof |
CN107095308A (en) * | 2017-07-03 | 2017-08-29 | 广东格物生物科技有限公司 | A kind of probiotics preparation and its application |
CN107118981A (en) * | 2017-04-28 | 2017-09-01 | 广东格物生物科技有限公司 | A kind of probiotics preparation and its application for being used to nurse one's health enteric microorganism environment |
-
2017
- 2017-09-20 CN CN201710854857.3A patent/CN107467670B/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1104039A (en) * | 1993-12-22 | 1995-06-28 | 黄明和 | Chengji additive for fodder |
CN101580799A (en) * | 2008-05-14 | 2009-11-18 | 北京大北农科技集团股份有限公司 | Micro-ecological preparation and application thereof |
CN103209600A (en) * | 2010-11-15 | 2013-07-17 | 雀巢产品技术援助有限公司 | Array of age-tailored nutritional formula with probiotics |
CN102106491B (en) * | 2011-02-24 | 2013-03-20 | 海一(厦门)生物科技有限公司 | High-activity biological fermentation feed for prawn and preparation method thereof |
CN102409015A (en) * | 2011-12-06 | 2012-04-11 | 北京大北农科技集团股份有限公司 | Composite microecological preparation, application thereof in feed additive and premix |
CN102559545A (en) * | 2011-12-15 | 2012-07-11 | 北京大北农科技集团股份有限公司 | Composite micro-ecological preparation for aquatic product and premix thereof |
CN102640855A (en) * | 2012-04-27 | 2012-08-22 | 杨洪星 | Micro ecological feed additive |
CN103583850A (en) * | 2012-08-17 | 2014-02-19 | 广州市纽溢乐商贸有限公司 | Preparation method of composite microecologics, and fermenting equipment of preparation method |
CN103349186A (en) * | 2013-08-01 | 2013-10-16 | 正大康地(澄海)有限公司 | Weaned piglet feed additive and preparation method thereof |
CN104206734A (en) * | 2014-09-03 | 2014-12-17 | 湛秀河 | Chinese medicinal herb nonreactor biological feed additive |
CN106306363A (en) * | 2016-07-20 | 2017-01-11 | 洛阳欧科拜克生物技术股份有限公司 | Composite probiotic product formula and production technology thereof |
CN107118981A (en) * | 2017-04-28 | 2017-09-01 | 广东格物生物科技有限公司 | A kind of probiotics preparation and its application for being used to nurse one's health enteric microorganism environment |
CN107095308A (en) * | 2017-07-03 | 2017-08-29 | 广东格物生物科技有限公司 | A kind of probiotics preparation and its application |
Non-Patent Citations (1)
Title |
---|
胡晓芬等: "益生菌缓解抗生素对生长猪饲料干物质消化率及后肠微生物的影响", 《养猪》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108902517A (en) * | 2018-05-16 | 2018-11-30 | 浙江省中医药研究院 | A kind of probiotic composition and its application |
CN113430150A (en) * | 2021-08-11 | 2021-09-24 | 真爱生命生物技术(重庆)有限公司 | Probiotics and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN107467670B (en) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103484288B (en) | Method for improving effect of medicinal liquor and probiotic composition | |
CN101612169B (en) | Inactivated lactobacillus micro-ecological preparation and preparation method thereof | |
KR100433300B1 (en) | Feed product | |
CN104396869B (en) | A kind of mountain swine rearing method | |
CN102972638B (en) | Animal feed additive and preparation method thereof | |
CN104758318B (en) | A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate | |
CN106834163A (en) | Feed fermentation agent, fermented feed and preparation method thereof | |
EP1867238B1 (en) | Feeding stuff composition comprising proliferation promoting agent for bifidus bacteria and use of the same | |
CN102028110A (en) | Probiotic-astragalus polysaccharide composition for feeding commercial chicken | |
CN109007370A (en) | Complex function additive for feed for piglets and preparation method thereof | |
CN110292114A (en) | A kind of fermented feed that Yak Growth performance can be improved | |
CN101999556B (en) | Special animal nutrient for beef cattle and preparation method thereof | |
CN107467670A (en) | A kind of probiotics preparation and preparation method and application | |
CN101219154A (en) | Microorganism additive agent for improving phylactic power of pets and accelerating growth | |
CN109198209A (en) | A kind of production method and its application of fermented maize | |
US20210177028A1 (en) | Improved human food product | |
KR20080054912A (en) | The process of manufacturing fermented soybeans pill | |
CN109221697A (en) | Weaned piglets probiotic feed and preparation method thereof | |
CN105284735A (en) | Method for feeding drug residue-free Wenshang Luhua cock at age of 6-18 weeks | |
CN105941934A (en) | Starter feed for Bama miniature pigs | |
CN110419622A (en) | A kind of compound probiotic oligosaccharides fruit feed additive and its preparation application method | |
CN112544782A (en) | Composite microecological preparation and preparation method and application thereof | |
CN111758834A (en) | Special strain formula for livestock and poultry breeding industry | |
CN110876429A (en) | Red date powder feed fermentation base material for poultry | |
CN108902499A (en) | A kind of piglet perfect compound feed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |